Valanx Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company focuses on creating SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents to produce antibody-drug conjugates for cancer treatment. This technology also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Valanx Biotech offers bioanalytics and mass spectrometry services to meet specific client needs, enhancing the efficiency and effectiveness of protein-drug conjugate development.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
BirdShades specializes in the development of a transparent window film designed to enhance the visibility of glass to birds, thereby reducing the risk of collisions. Their innovative self-adhesive film allows businesses and consumers to protect avian life by making glass surfaces more detectable to birds. This solution addresses a significant environmental concern, helping to mitigate the dangers posed by clear glass in buildings and other structures. By providing a practical way to prevent bird fatalities, BirdShades contributes to wildlife conservation efforts while promoting awareness of the impact of urban design on bird populations.
Valanx Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company focuses on creating SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents to produce antibody-drug conjugates for cancer treatment. This technology also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Valanx Biotech offers bioanalytics and mass spectrometry services to meet specific client needs, enhancing the efficiency and effectiveness of protein-drug conjugate development.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.
Valanx Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company focuses on creating SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents to produce antibody-drug conjugates for cancer treatment. This technology also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Valanx Biotech offers bioanalytics and mass spectrometry services to meet specific client needs, enhancing the efficiency and effectiveness of protein-drug conjugate development.
BirdShades specializes in the development of a transparent window film designed to enhance the visibility of glass to birds, thereby reducing the risk of collisions. Their innovative self-adhesive film allows businesses and consumers to protect avian life by making glass surfaces more detectable to birds. This solution addresses a significant environmental concern, helping to mitigate the dangers posed by clear glass in buildings and other structures. By providing a practical way to prevent bird fatalities, BirdShades contributes to wildlife conservation efforts while promoting awareness of the impact of urban design on bird populations.
BirdShades specializes in the development of a transparent window film designed to enhance the visibility of glass to birds, thereby reducing the risk of collisions. Their innovative self-adhesive film allows businesses and consumers to protect avian life by making glass surfaces more detectable to birds. This solution addresses a significant environmental concern, helping to mitigate the dangers posed by clear glass in buildings and other structures. By providing a practical way to prevent bird fatalities, BirdShades contributes to wildlife conservation efforts while promoting awareness of the impact of urban design on bird populations.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.
Robo Wunderkind is a startup based in Vienna, Austria. We build tools that enhance the way kids play, learn, and create with tech in school and at home. Our award-winning robotics kits empower kids to learn to code through the joy of play. Based in Vienna as well as San Francisco, California. In the summer of 2014, the team was part of the first worldwide hardware accelerator HAX. The progress made there was incorporated into Robo, earning them the "Robot of the Year" Award from Festo and the Austrian Startup of the Year Award in 2015.
Valanx Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company focuses on creating SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents to produce antibody-drug conjugates for cancer treatment. This technology also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Valanx Biotech offers bioanalytics and mass spectrometry services to meet specific client needs, enhancing the efficiency and effectiveness of protein-drug conjugate development.
Valanx Biotech GmbH, founded in 2017 and based in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company focuses on creating SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with therapeutic agents to produce antibody-drug conjugates for cancer treatment. This technology also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Valanx Biotech offers bioanalytics and mass spectrometry services to meet specific client needs, enhancing the efficiency and effectiveness of protein-drug conjugate development.
B2Holding ASA provides debt solutions for banks and institutional vendors. The company’s portfolio of business consists of purchase, management, and collection of unsecured and secured non-performing loans. It services include debt purchase and collection, credit information third party debt collection, and consumer lending, as well as telemarketing and fraud prevention services. It principally operates in Norway, Sweden, Denmark, Finland, Estonia, Latvia, Lithuania, Poland, Croatia, Slovenia, Serbia, Montenegro, Bosnia-Herzegovina, Austria, the Czech Republic, Hungary, Spain, Portugal, Italy, France, Bulgaria, Romania, Greece, and Cyprus. B2Holding SAS was founded in 2011 and is headquartered in Oslo, Norway.
Ageria Ltd. is a biotechnology company focused on developing yogurt enriched with health-promoting compounds, specifically targeting anti-aging benefits. Incorporated in 2015 and based in Vienna, Austria, Ageria utilizes a longevity compound known as Spermidine in its yogurt production. The company employs naturally engineered yogurt bacteria to enhance the health benefits of its products. With a commitment to advancing human longevity and well-being, Ageria aims to provide consumers with yogurt that supports a longer and healthier life.
Ageria Ltd. is a biotechnology company focused on developing yogurt enriched with health-promoting compounds, specifically targeting anti-aging benefits. Incorporated in 2015 and based in Vienna, Austria, Ageria utilizes a longevity compound known as Spermidine in its yogurt production. The company employs naturally engineered yogurt bacteria to enhance the health benefits of its products. With a commitment to advancing human longevity and well-being, Ageria aims to provide consumers with yogurt that supports a longer and healthier life.
Saphium Biotechnology GmbH, established in 2015 and located in Kapfenstein, Austria, specializes in the production of bio-based plastics derived from microbes. The company's flagship product, PHAbulous Filaments, offers a sustainable alternative to conventional plastics, which are typically made from crude oil and can take centuries to decompose while releasing harmful toxins. Saphium's bioplastics are non-toxic, fully compostable, and designed for a variety of applications, including 3D printing and food packaging. Unlike traditional plastics, Saphium's materials break down within 60 days in soil, leaving no harmful residue and even enriching the soil as they decompose. Through its innovative approach, Saphium aims to provide environmentally friendly solutions that address the pressing issues of plastic waste.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.
Robo Wunderkind is a startup based in Vienna, Austria. We build tools that enhance the way kids play, learn, and create with tech in school and at home. Our award-winning robotics kits empower kids to learn to code through the joy of play. Based in Vienna as well as San Francisco, California. In the summer of 2014, the team was part of the first worldwide hardware accelerator HAX. The progress made there was incorporated into Robo, earning them the "Robot of the Year" Award from Festo and the Austrian Startup of the Year Award in 2015.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.